A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476156A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melanocortin-4 receptor agonists
11/17/2004	EP1476155A2 Methods and compositions for reducing the development of drug tolerance and/or physical dependence
11/17/2004	EP1476154A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
11/17/2004	EP1476153A2 Method of treating and preventing bone loss
11/17/2004	EP1476152A2 Use of melatonin analogues for induction of general anesthesia
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1476150A2 Carboxyfullerenes and methods of use thereof
11/17/2004	EP1476149A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
11/17/2004	EP1476148A2 Partial dopamine-d2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity
11/17/2004	EP1476147A1 Methods for treating eye disorders
11/17/2004	EP1476146A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
11/17/2004	EP1476145A1 Anti-nausea and anti-vomiting activity of cannabidiol compounds
11/17/2004	EP1476144A1 Synergistic mixtures of o-phenylphenol and other nitrogen and aldehyde microbiocides
11/17/2004	EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004	EP1476142A1 Compositions for pulmonary administration
11/17/2004	EP1476141A2 Tamper-resistant transdermal opioid delivery devices
11/17/2004	EP1476139A1 Controlled release dosage forms
11/17/2004	EP1476138A2 Modified release formulations of at least one form of tramadol
11/17/2004	EP1476136A1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation
11/17/2004	EP1476131A2 Compositions and methods for delivery of skin cosmeceuticals
11/17/2004	EP1476128A2 Lipase inhibiting composition
11/17/2004	EP1476127A1 Nsaid-containing topical formulations that demonstrate chemopreventive activity
11/17/2004	EP1476121A1 Topical ivermectin composition
11/17/2004	EP1476081A2 Method and process for producing youthful-appearing, small-pored, and smooth skin
11/17/2004	EP1476032A1 Water dispersible coenzyme q10 dry powders
11/17/2004	EP1476031A1 Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
11/17/2004	EP1476019A1 Aqueous antiseptic based on bispyridiniumalkanes
11/17/2004	EP1401442B1 S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
11/17/2004	EP1392713A4 Liver x receptor agonists
11/17/2004	EP1390063B1 Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1319006B1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
11/17/2004	EP1318804B1 Iron compositions
11/17/2004	EP1311508B1 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
11/17/2004	EP1301077B1 Antimicrobial composition useful for the treatment of bovine mastitis
11/17/2004	EP1296983B1 Novel process for the preparation of pyrazolopyrimidinones
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1286990B1 Stolonoxides
11/17/2004	EP1283672B1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
11/17/2004	EP1274700B1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1257261B1 Antiviral pharmaceutical compositions containing iron chelators
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1250340B1 Methods and compounds for inhibiting mrp1
11/17/2004	EP1248620B1 A new use of levosimendan
11/17/2004	EP1242436B1 Oligosaccharide mixture
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1221867B1 Nutritional composition comprising an anandamide precursor
11/17/2004	EP1214323B1 Indoloazepines as vasopressin receptor antagonists
11/17/2004	EP1185274B1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
11/17/2004	EP1176968B1 Selenium-containing pro-drugs for cancer therapy
11/17/2004	EP1171120A4 Methods for alleviating discomfort of a hot flash and compositions therefor
11/17/2004	EP1165560B1 2-hydroxy methylcyclopro pylidenemethyl purines as antiviral agents
11/17/2004	EP1156999B1 Method for the preparation of a chiral-beta-amino ester
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1109809B1 Pyrroloquinolines for treatment of obesity
11/17/2004	EP1105101B1 Compositions and methods for treating intracellular infections
11/17/2004	EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004	EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004	EP1087762B1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1075471B1 Indolyl derivatives as serotonergic agents
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP1073469B1 Stable mitoxantron solutions
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP1054994B1 Fermentative preparation process for cytostatics and crystal forms thereof
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	EP1014980B1 Use of tempol for the treatment of essential hypertension
11/17/2004	EP1000071B1 Gaba-c receptor antagonists for stimulating memory capacity
11/17/2004	EP0980255B1 Adhesion prevention and an endoscopic insufflation system therefor
11/17/2004	EP0973766B1 Quinoxalinediones
11/17/2004	EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004	EP0942928B1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP0942732B1 Use of nk-1 receptor antagonists for treating movement disorders
11/17/2004	EP0942731B1 Use of nk-1 receptor antagonists for treating substance use disorders
11/17/2004	EP0933995B1 Method of treating endothelial injury
11/17/2004	EP0928190B1 Nucleic acid particle delivery
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	EP0919628B1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof
11/17/2004	EP0904093A4 Administration of polypeptide growth factors following central nervous system ischemia or trauma
11/17/2004	EP0873128B1 Oral administration of effective amounts of forms of hyaluronic acid
11/17/2004	EP0832092B1 Orally active adenosine kinase inhibitors
11/17/2004	EP0777491B1 Use of tasteless, hydrolysed collagen and agent containing the same
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	EP0652972B1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure
11/17/2004	CN1547672A Ultrasonic doppler effect speed measurement
11/17/2004	CN1547585A Inosine L-arginine salt and uses thereof
11/17/2004	CN1547584A Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives and related treatment methods
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547581A 二氮杂萘衍生物 Naphthyridine derivatives
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547578A Aminopyrrole compounds as antiinflammatory agents
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/17/2004	CN1547570A Substituted c-cyclohexylmethylamine derivatives
11/17/2004	CN1547486A Antibodies to OPGL
11/17/2004	CN1547484A Pharmaceutical dosage form of amorphous nelfinavir mesylate

1 ... 4890 4891 4892 4893 4894 4895 4896 4897 4898 4899 4900 4901 4902 4903 4904 4905 4906 4907 4908 4909 4910 ... 7860